These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12651631)

  • 1. Bovine thrombin and systemic autoimmunity.
    Cronstein BN
    Am J Pathol; 2003 Apr; 162(4):1389; author reply 1389-90. PubMed ID: 12651631
    [No Abstract]   [Full Text] [Related]  

  • 2. Exposure of mice to topical bovine thrombin induces systemic autoimmunity.
    Schoenecker JG; Johnson RK; Lesher AP; Day JD; Love SD; Hoffman MR; Ortel TL; Parker W; Lawson JH
    Am J Pathol; 2001 Nov; 159(5):1957-69. PubMed ID: 11696457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function.
    Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK
    Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihuman factor V antibodies after use of relatively pure bovine thrombin.
    Lawson JH; Lynn KA; Vanmatre RM; Domzalski T; Klemp KF; Ortel TL; Niklason LE; Parker W
    Ann Thorac Surg; 2005 Mar; 79(3):1037-8. PubMed ID: 15734434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical safety of recombinant human thrombin.
    Heffernan JK; Ponce RA; Zuckerman LA; Volpone JP; Visich J; Giste EE; Jenkins N; Boster D; Pederson S; Knitter G; Palmer T; Wills M; Early RJ; Rogge MC
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):48-58. PubMed ID: 16971028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylactic reaction to topical bovine thrombin.
    Rothenberg DM; Moy JN
    Anesthesiology; 1993 Apr; 78(4):779-82. PubMed ID: 8096685
    [No Abstract]   [Full Text] [Related]  

  • 7. A method for preparation of dry thrombin for topical application.
    Tsvetkov T; Bucureshtliev A; Alexiev N; Nicolov C; Bucureshtlieva R; Mincheff M
    Cryobiology; 1984 Dec; 21(6):661-3. PubMed ID: 6518803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
    Ofosu FA; Crean S; Reynolds MW
    Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
    Lo CY; Jones C; Glader B; Zehnder JL
    Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of antibodies to the topical hemostat bovine thrombin.
    Randleman CD; Singla NK; Renkens KL; Souza S; Pribble JP; Alexander WA
    J Am Coll Surg; 2010 Dec; 211(6):798-803. PubMed ID: 20980172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
    Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
    J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure.
    Savage WJ; Kickler TS; Takemoto CM
    Pediatr Blood Cancer; 2007 Dec; 49(7):1025-9. PubMed ID: 16526049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative bleeding induced by topical bovine thrombin: report of two cases.
    Christie RJ; Carrington L; Alving B
    Surgery; 1997 Jun; 121(6):708-10. PubMed ID: 9186473
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature.
    Rodgers GM
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):86-8. PubMed ID: 21228719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of antibodies to topical bovine thrombin after abdominal hysterectomy. A case report.
    Adams JD; Jones S; Brost BC
    J Reprod Med; 2001 Oct; 46(10):909-12. PubMed ID: 11725736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin.
    Ortel TL; Mercer MC; Thames EH; Moore KD; Lawson JH
    Ann Surg; 2001 Jan; 233(1):88-96. PubMed ID: 11141230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative topical bovine thrombin exposure is not associated with hemodialysis graft thrombosis.
    Vannorsdall MD; Arkel YS; Ku DH; Lucas FL; Himmelfarb J
    Kidney Int; 2003 Aug; 64(2):690-6. PubMed ID: 12846767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative coagulopathy in a pediatric patient after exposure to bovine topical thrombin.
    Crow SS; Sullivan VV; Aysola AE; Key NS; Harker-Murray P; Foker JE; Steiner ME
    Ann Thorac Surg; 2007 Apr; 83(4):1547-9. PubMed ID: 17383385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a factor V and thrombin inhibitor following partial hepatic resection and the use of topical thrombin concentrate.
    Cruickshank MK; Black J; Wall W
    Clin Lab Haematol; 1994 Jun; 16(2):187-90. PubMed ID: 7955928
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
    Clark JA; Humphries JE; Crean S; Reynolds MW
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):107-14. PubMed ID: 20014051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.